1-4 of 4
Elke Schaeffeler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

No association between the presence of killer-cell immunoglobulin-like receptor genes and susceptibility to childhood ALL

Lena Oevermann, Matthias Firnkorn, Sebastian Michaelis, Simon Müller, Elke Schaeffeler, Martin Schrappe, Gunnar Cario, Martin Stanulla, Matthias Schwab, Rupert Handgretinger, Markus Mezger
Journal: Blood
Blood (2015) 125 (21): 3355–3357.
https://doi.org/10.1182/blood-2015-02-628339
Published: 2015
Journal Articles

Warfarin pharmacogenetics meets clinical use

Matthias Schwab, Elke Schaeffeler
Journal: Blood
Blood (2011) 118 (11): 2938–2939.
https://doi.org/10.1182/blood-2011-07-367763
Published: 2011
Journal Articles

Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols

Brief Report
Martin Stanulla, Elke Schaeffeler, Anja Möricke, Sally A. Coulthard, Gunnar Cario, André Schrauder, Peter Kaatsch, Michael Dördelmann, Karl Welte, Martin Zimmermann, Alfred Reiter, Michel Eichelbaum, Hansjörg Riehm, Martin Schrappe, Matthias Schwab
Journal: Blood
Blood (2009) 114 (7): 1314–1318.
https://doi.org/10.1182/blood-2008-12-193250
Published: 2009
Journal Articles

Thiopurine methyltransferase Genotype Is Not a Risk Factor for Secondary Malignant Neoplasias after Treatment for Childhood Acute Lymphoblastic Leukemia on Berlin-Frankfurt-Muenster Protocols.

Martin Stanulla, MD, Elke Schaeffeler, PhD, Anja Moericke, MD, Gunnar Cario, MD, Michel Eichelbaum, MD, Hansjoerg Riehm, MD, Karl Welte, MD, Martin Schrappe, MD, Matthias Schwab, MD
Journal: Blood
Blood (2006) 108 (11): 150.
https://doi.org/10.1182/blood.V108.11.150.150
Published: 2006